|

SAF-189s Clinical Trials

1 actively recruiting trial

Also known as: foritinib succinate

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.1

Indications

  • Lung Cancer, Nonsmall Cell1
  • Advanced Cancer1
  • Advanced Solid Tumor1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.